Delivery Order SPE2DB22D1106-SPE2DB25FFCA4
Award Date 8/7/25
Potential Completion Date 8/8/25
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,169.75 to AmerisourceBergen Drug Corp for the supply of Naloxone 2 mg/2 ml syringes on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Naloxone Hydrochloride, valued at $1,206.73. This firm fixed price delivery order, with an ultimate completion date of September 18, 2025, represents a non-competitive award under an existing contract vehicle. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,120.08 to AmerisourceBergen Drug Corp for the supply of Naloxone 2 mg/2 ml syringes on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a $1,018.53 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Naloxone 0.4 mg/mL vials. This competitively awarded, firm fixed-price contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Naloxone Hydrochloride with a ceiling value of $1,211.66. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded with no set-aside...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Naloxone 2 mg/2 mL syringes with a ceiling value of $4,705.66. This is a firm fixed-price delivery order with an ultimate completion date of August 19, 2025, and represents a non-competed award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. No small business...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain on August 25, 2025, to supply Naloxone 4 mg/10 mL vials with a ceiling value of $9,855.31 and a firm fixed price contract type. The order was completed as a child delivery order under a larger indefinite delivery contract vehicle with an ultimate completion date of August 26, 2025. This non-competitive award reflects AmerisourceBergen's established role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a $3,943.73 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Naloxone 2 mg/2 ml syringes. This non-set-aside contract, awarded on June 2, 2025, with an ultimate completion date of June 3, 2025, represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, supporting federal medical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Naloxone 0.4 mg/mL vials with a ceiling value of $1,444.42. This is a firm fixed-price delivery order with an ultimate completion date of August 4, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The contract contains no...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $45,568.82 on July 14, 2025, for the supply of Naloxone 4MG Nasal in 2-count units. This competitive, firm fixed-price delivery order is scheduled for ultimate completion by August 8, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA...